12 significant markers were screened and finally optimized to obtain the marker combination made up of 8 lung cancer autoantibodies, including those targeting ZNF573, BRAF, SOX2, MAGE.A4, BMI1, FXR1, HuC, and ESO1. This evidence concerns the gene BRAF and lung cancer.